During the past decade, First Hospital of Lanzhou University conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "First Hospital of Lanzhou University" #1 sponsor was "BeiGene" with 3 trials, followed by "Lifetech Scientific (Shenzhen) Co., Ltd." with 2 trials sponsored, "Betta Pharmaceuticals Co., Ltd." with 1 trials sponsored, "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 1 trials sponsored and "Shanghai Junshi Bioscience Co., Ltd." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "First Hospital of Lanzhou University" are "Abdominal Aortic Aneurysm" (1 trials), "Adenocarcinoma" (1 trials), "Advanced Hepatocellular Carcinoma (HCC)" (1 trials), "Chronic Kidney Disease" (1 trials) and "Diabetes Mellitus" (1 trials). Many other conditions were trialed in "First Hospital of Lanzhou University" in a lesser frequency.

Most popular intervention types in "First Hospital of Lanzhou University" are "Drug" (7 trials), "Device" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Tislelizumab" (2 trials), "AK105 injection" (1 trials), "Abdominal Aortic Aneurysm Stent Graft System" (1 trials), "Anlotinib hydrochloride capsule" (1 trials) and "Artery Stent Graft System" (1 trials). Other intervention names were less common.

The vast majority of trials in "First Hospital of Lanzhou University" are 9 trials for "All" genders.

Currently, there are NaN active trials in "First Hospital of Lanzhou University". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 1 completed trials in First Hospital of Lanzhou University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in First Hospital of Lanzhou University, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".